- Home
- Companies
- Moon (Guangzhou) Biotech Co.,Ltd
- Products
- Moon Biotech - Microbiome Therapeutics
Moon Biotech - Microbiome Therapeutics
From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based drugs for improving human health and treating diseases. MoonBiotech is moving to a clinical-stage biotech company focused on the development of innovative microbiome-driven therapeutics. Our proprietary Moon Culture-To-Product® Microbiome Technology Platform empower us to systematically, precisely and rapidly discover full spectrum microbe-based drugs via the established bioinformatics, microbial, genetics and metabolites resources.
Why MOON LBPs?
Live biotherapeutics Products (LBPs) are a regulated, emergent and revolutionary new class of medicine and transforms how diseases are treated. Utilizing our exceptional science and platform, our innovative Moon LBPs are discovered, developed and delivered to meet the demands of treatment of many diseases. Moon LBPs precisely target the central hub of interconnective manner of microbiome, gut, metabolism and immunity. The therapeutic attractiveness of Moon LBPs relies on their characteristics of strong Safety, effective Robustness, combinational Synergy, and rapid progress to Clinical development.
Safety
Tightly-regulated gut microbes from healthy human individuals
Robustness
Highly effective with a unique property of mechanism precisely targeting integrative hub
Synergy
Strong synergistic effect with current therapeutic drugs
Clinical
Rapid advancing to clinical development
